Surgical management for a malignant bowel obstruction with recurrent gastrointestinal carcinoma

Journal of Surgical Oncology

Volumn 101, Issue 3, 2010, Pages 228-232

  Amikura, Katsumi ^a   Sakamoto, Hirohiko ^a   Yatsuoka, Toshimasa ^a   Kawashima, Yoshiyuki ^a   Nishimura, Yoji ^a   Tanaka, Yoichi ^a  

^a SAITAMA CANCER CENTER   (Japan)

Author keywords

Malignant bowel obstruction; Peritonitis carcinomatosis; Recurrent gastrointestinal carcinoma; Surgical management

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; LEVOFOLINATE CALCIUM; METHOTREXATE; OXALIPLATIN; PACLITAXEL; UNCLASSIFIED DRUG;

ARTICLE; ASCITES; BILE DUCT CARCINOMA; CARCINOMATOUS PERITONITIS; COLON CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; ESOPHAGUS CARCINOMA; GASTROINTESTINAL CARCINOMA; HUMAN; INFORMED CONSENT; INTESTINE FISTULA; INTESTINE OBSTRUCTION; MAJOR CLINICAL STUDY; MALIGNANT BOWEL OBSTRUCTION; MEAL; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PANCREAS CARCINOMA; PNEUMONIA; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RECTUM CARCINOMA; RECURRENT CANCER; STOMACH CARCINOMA; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; WOUND INFECTION;

GASTROINTESTINAL NEOPLASMS; HUMANS; INTESTINAL OBSTRUCTION; NEOPLASM RECURRENCE, LOCAL;

EID: 77249152307     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21463     Document Type: Article

References (23)

1. Krouse RS: Surgical management of malignant bowel obstruction. Surg Oncol Clin N Am 2004;13:479-490.
2. Feuer DJ, Broadley KE, Shephered JH, et al.: Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer. Gynecol Oncol 1999;75:313-322.
3. Yazdi GP, Miedema BW, Humphrey LJ: High mortality after abdominal operation in patients with large-volume malignant ascites. J Surg Oncol 1996;62:93-96.
4. Ripamonti C, Panzeri C, Gruff L, et al.: The role of somatostatin and octreotide in bowel obstruction: Pre-clinical and clinical results. Tumori 2001;87:1-9.
5. Osteen RT, Guyton S, Steele G, Jr., et al.: Malignant intestinal obstruction. Surgery 1980;87:611-615.
6. Higashi H, Shida H, Ban K, et al.: Factors affecting successful palliative surgery for malignant bowel obstruction due to peritoneal dissemination from colorectal cancer. Jpn J Clin Oncol 2003;33:357-359.
7. Lau PW, Lorentz TG: Related articles, links results of surgery for malignant bowel obstruction in advanced, unresectable, recurrent colorectal cancer. Dis Colon Rectum 1993;36:61-64.
8. Blair SL, Chu DZJ, Schwarz RE: Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer. Ann Surg Oncol 2001;8:632-637.
9. Ripamonti C, Conno FD, Ventafridda V, et al.: Management of bowel obstruction in advanced and terminal cancer patients. Ann Oncol 1993;4:15-21.
10. Legendre H, Vanhuyse F, Caroli-Bosc FX, et al.: Survival and quality of life after palliative surgery for neoplastic gastrointestinal obstruction. Eur J Surg Oncol 2001;27:364-367.
11. Annest LS, Jolly PC: The results of surgical treatment of bowel obstruction caused by peritoneal carcinomatosis. Am Surg 1979; 45:718-721.
12. Butler JA, Cameron BL, Morrow M, et al.: Small bowel obstruction in patients with a prior history of cancer. Am J Surg 1991;162:624-628.
13. Barnett WO: Problems in abdominal surgery VI. Intestinal obstruction from peritoneal carcinomatosis. J Miss State Med Assoc 1976;17:325-327.
14. Ooijen BV, Burg MEL, Planting AST, et al.: Surgical treatment or gastric drainage only for intestinal obstruction in patients with carcinoma of the ovary or peritoneal carcinomatosis of other origin. Surg Gynecol Obstet 1993;176:469-474.
15. Khoo D, Riley J, Waxman J: Control of emesis in bowel obstruction in terminal ill patients. Lancet 1992;339:375-376.
16. Potluri V, Zhukovsky DS: Recent advances in malignant bowel obstruction: An interface of old and new. Curr Pain Headache Rep 2003;7:270-278.
17. Averbach AM, Sugarbaker PH: Recurrent intraabdominal cancer causing intestinal obstruction: Washington Hospital Cancer Center experience with 42 patients managed by surgery and intraoperative chemotherapy. Cancer Treat Res 1996;81:133-147.
18. KoizumiW, Narahara H, Hara T, et al.: S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): A phase III trial Lancet Oncol. 2008;9:215-221.
19. Yamao T, Shimada Y, Shirao K, et al.: Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: A Report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial. Jpn J Clin Oncol 2004;34:316-322.
20. Otsu A, Boku N, Tamura F, et al.: An early phase II study of a 3-hour infusion of paclitaxel for advanced gastric cancer. Am J Clin Oncol 1998;21:416-419.
21. Hironaka S, Zenda S, Boku N, et al.:Weekly paclitaxel as secondline chemotherapy for advanced or recurrent gastric cancer. Gastric Cancer 2006;9:14-18.
22. Burris HA III, Moore MJ, Andersen J, et al.: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial. J Clin Oncol 1997;15:2403-2413.
23. Goldberg RM, Sargent DJ, Morton RF, et al.: A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal carcinoma. Clin Oncol 2004;22:4-6.